Sort
46,585 grants matching “heart failure”
Cardiomyopathy Genomes Project
$557,218Elizabeth M McNally · Northwestern University At Chicago · R01 · FY2015 · HL
SK current and ventricular arrhythmias.
$557,134Peng-Sheng Chen · Indiana University Indianapolis · R01 · FY2019 · HL
SK current and ventricular arrhythmias.
$557,134Peng-Sheng Chen · Indiana University Indianapolis · R01 · FY2020 · HL
Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure
$557,071Shey-Shing Sheu · Thomas Jefferson University · R01 · FY2024 · HL
Microfluidic organoid model of cardio-hepatic physiology and disease
$557,067David Sachs · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
Nutritional Restriction and Activity Thermogenesis
$557,059James A Levine · Mayo Clinic Rochester · R01 · FY2007 · DK
Early Detection of Heart Failure via the Electronic Health Record in Primary Care
$557,031Walter F Stewart · California Pacific Med Ctr Res Institute · R01 · FY2013 · HL
An expandable polymeric valved conduit to repair congenital heart disease
$557,018David Kalfa · Columbia University Health Sciences · R01 · FY2023 · HL
Investigation of calcium modulation in cardiomyocytes by novel methods
$556,972Steven O Marx · Columbia University Health Sciences · R01 · FY2016 · HL
PPARα induces IL-6 to trigger diabetic cardiomyopathy
$556,954Junichi Sadoshima · Rbhs-New Jersey Medical School · R01 · FY2021 · HL
Role of Diabetes in MERS Coronavirus Pathogenesis
$556,863Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2021 · AI
Cardiac Myosins and Heart Failure
$556,837Jeffrey Robbins · University Of Cincinnati · P50 · FY2009 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension
$556,650Vinicio A De Jesus Perez · Stanford University · R01 · FY2019 · HL
Novel Strategy of PDE5-mTOR Inhibition in Attenuation of Cancer Drug Cardiotoxicity
$556,570Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2022 · HL
Preparing for Genomic Editing Technologies: An Anticipatory Approach
$556,468Christopher Thomas Scott · Baylor College Of Medicine · R01 · FY2021 · HG
Support for the recruit of a tenure track faculty member, Lie Gao, M.D., Ph.D.
$556,414Irving H Zucker · University Of Nebraska Medical Center · P30 · FY2009 · HL
Assessing The Impact of Neighborhood and Interpersonal Discrimination on Obesity and Leukocyte Gene Expression
$556,373Adolfo Cuevas · New York University · R01 · FY2024 · DK
Maladaptive Expression of Metabolic Enzymes and Activity in Heart Failure
$556,355E Douglas Lewandowski · Ohio State University · R01 · FY2019 · HL
Factor XIIa is the long-sought activator of circulating renin in heart failure.
$556,350Inna P Gladysheva · University Of Arizona · R01 · FY2025 · HL
Coronary Vasculature Progenitor Cell in Human Ischemic Heart Failure
$556,240Piero Anversa · Brigham And Women'S Hospital · R01 · FY2008 · HL
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
$556,205Michael Regnier · University Of Washington · R01 · FY2013 · HL
Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System
$556,155Peter G Jacobs · Oregon Health & Science University · R01 · FY2022 · DK
Role of titin in the pathophysiology of diaphragm weakness during mechanical ventilation
$556,120Coen Ottenheijm · University Of Arizona · R01 · FY2023 · HL
Maladaptive Expression of Metabolic Enzymes and Activity in Heart Failure
$556,059E Douglas Lewandowski · Ohio State University · R01 · FY2018 · HL
Prevention of Cardiac Cell Death by Mst1 inhibitor
$556,030Junichi Sadoshima · Vasade Biosciences, Inc. · R42 · FY2011 · HL